These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8907798)

  • 21. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
    Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y
    Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
    Miyamoto S; Zhu B; Teramatsu T; Aye NN; Hashimoto K
    Eur J Pharmacol; 2000 Jul; 400(2-3):263-9. PubMed ID: 10988343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a new antiarrhythmic drug, SD-3212, on canine ventricular arrhythmia models.
    Hirasawa A; Haruno A; Matsuzaki T; Hashimoto K
    Jpn Heart J; 1992 Nov; 33(6):851-61. PubMed ID: 1299746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-arrhythmic agents in ischemic heart disease: supraventricular arrhythmias, digitalis toxicity and chronic stable ventricular ectopic beats.
    Opie LH
    Methods Find Exp Clin Pharmacol; 1982; 4(1):25-35. PubMed ID: 7087606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
    Gomoll AW
    Arzneimittelforschung; 1987 Jul; 37(7):787-94. PubMed ID: 3118889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
    Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
    Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
    Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of KT-362, a new Na and Ca influx and Ca release inhibitor, on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Mochizuki S; Tomiyama A
    Jpn J Pharmacol; 1989 Dec; 51(4):475-82. PubMed ID: 2559225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models.
    Arita J; Xue YX; Aye NN; Fukuyama K; Wakui Y; Niitsu K; Maruno M; Siying C; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 318(2-3):333-40. PubMed ID: 9016923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.
    Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K
    Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Eur J Pharmacol; 2000 Jun; 398(1):107-12. PubMed ID: 10856454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
    Akiyama K; Hashimoto K
    Jpn Heart J; 1989 Jul; 30(4):487-95. PubMed ID: 2509760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
    Hashimoto K; Satoh H; Shibuya T; Imai S
    J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.